New cancer clinical trial: Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer

Published on: August 27, 2018 at 12:00PM
Condition:   Breast Cancer
Interventions:   Drug: Abraxane;   Drug: Xeloda
Sponsor:   Zhejiang Cancer Hospital
Not yet recruiting
https://ift.tt/2NpC1Yx